Detailed information for selected cell line:
Cell Line: |
HS799; Huntington's disease mutation
|
NIH Registration Number: |
0207
|
NIH Approval Number: |
NIHhESC-13-0207
|
Available for Distribution: |
Yes
- Through Stockholm Medical Biobank when a valid Material Transfer Agreement (MTA) exists.
|
Provider Restrictions: |
1. An ethical approval by the Swedish Ethical Review Authority and agreement that regulates the existing research project´s access to Healthcare Principal´s Biobank (Biobank Agreement) is required in order to set up a Material Transfer Agreement (MTA). 2. The human biological samples can be sent outside Sweden from a Swedish biobank by a responsible Research Principal who intends to use the samples (material) for analyses as part of a research project that has been approved by the Swedish Ethical Review Authority. 3. When the planned analysis is finished, the samples should be either completely consumed during analyses, destroyed after the analyses, or returned back.
|
Additional Information: |
Line was derived from an embryo with mutations causing Huntington's disease.
|
NIH Restrictions: |
(No Additional Restrictions)
|
Submitting Organization: |
Karolinska Institute |
Provider Name: |
Stockholm Medical Biobank; Biobank number (IVO):914 (formerly Karolinska Institute)
|
Provider Phone: |
+46 8-517 725 52
|
Provider Email: |
biobankstockholm@regionstockholm.se; Fredrik.Lanner@ki.se; Ganesh.Acharya@ki.se
|
Provider URL: |
https://biobankstockholm.se
|
Approval Date: |
03/18/2013 |
View All Lines Eligible for Use
Go to NIH Form 2890 Login Page
Go to NIH Stem Cell Information Page
| |
NIH Form 2890:
- Login
Page
(Authorization Required)
Contact Us:
- Email questions to:
hescregistry@mail.nih.gov
(Emails that are offensive or unrelated to stem cells will be
deleted.)
|
|
|